Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Methicillin-resistant Staphylococcus Aureus: full-pipeline trial registry
2 of 6 indexed Methicillin-resistant Staphylococcus Aureus trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Methicillin-resistant Staphylococcus Aureus: 6 US clinical trials tracked, 2 recruiting.
Methicillin-resistant Staphylococcus Aureus is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Harvard Pilgrim Health Care, running 1 of these trials.
Enrollment posture brief
Registry condition methicillin-resistant-staphylococcus-aureus
OPEN 2 | RECR 33% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Methicillin-resistant Staphylococcus Aureus lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Methicillin-resistant Staphylococcus Aureus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Methicillin-resistant Staphylococcus Aureus is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Methicillin-resistant Staphylococcus Aureus research.
Harvard Pilgrim Health Care accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Methicillin-resistant Staphylococcus Aureus enrolment sits around 400 participants.
Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Methicillin-resistant Staphylococcus Aureus splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
PMT for MDRO Decolonization
University of Pennsylvania
NCT05632315
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
Indiana University
NCT06982105
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
Harvard Pilgrim Health Care
NCT00980980
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
University of Colorado, Denver
NCT00996112
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
West Virginia University
NCT01671358
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
Boston Medical Center
NCT01141101
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Methicillin-resistant Staphylococcus Aureus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Methicillin-resistant Staphylococcus Aureus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Methicillin-resistant Staphylococcus Aureus page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Methicillin-resistant Staphylococcus Aureus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Harvard Pilgrim Health Care sponsors the most Methicillin-resistant Staphylococcus Aureus trials on record, review their full trial history before evaluating a specific study. See Harvard Pilgrim Health Care's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Methicillin-resistant Staphylococcus Aureus condition card totals 6 registered trials; most-linked intervention Chlorhexidine bath and nasal mupirocin; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.